N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338

Author： Carter Percy H   Hynes John  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.11, 2010-11, pp. : 1609-1618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antagonists of IL-1R: a patent evaluation (WO2012122985)

By Sette Claudio  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 911-914

Informa Healthcare

Access to resources Recommend Favorite

AZD-4818, a chemokine CCR1 antagonist: WO2008103126 and WO2009011653

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 11, 2009-11 ,pp. : 1629-1633

Informa Healthcare

Access to resources Recommend Favorite

Clostridium difficile antibodies: a patent evaluation (WO2013028810)

By Lo Vecchio Andrea   Della Ventura Bartolomeo   Nicastro Emanuele  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 12, 2013-12 ,pp. : 1635-1640

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite

Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation

By Costantino Luca  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1099-1104

Informa Healthcare

Access to resources Recommend Favorite